334 related articles for article (PubMed ID: 25268716)
21. Multinuclear Organometallic Ruthenium-Arene Complexes for Cancer Therapy.
Babak MV; Ang WH
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394025
[TBL] [Abstract][Full Text] [Related]
22. Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.
Lazarević T; Rilak A; Bugarčić ŽD
Eur J Med Chem; 2017 Dec; 142():8-31. PubMed ID: 28442170
[TBL] [Abstract][Full Text] [Related]
23. Organoruthenium Complexes with C^N Ligands are Highly Potent Cytotoxic Agents that Act by a New Mechanism of Action.
Novohradsky V; Yellol J; Stuchlikova O; Santana MD; Kostrhunova H; Yellol G; Kasparkova J; Bautista D; Ruiz J; Brabec V
Chemistry; 2017 Nov; 23(61):15294-15299. PubMed ID: 28922506
[TBL] [Abstract][Full Text] [Related]
24. Anticancer ruthenium(III) complex KP1019 interferes with ATP-dependent Ca2+ translocation by sarco-endoplasmic reticulum Ca2+-ATPase (SERCA).
Sadafi FZ; Massai L; Bartolommei G; Moncelli MR; Messori L; Tadini-Buoninsegni F
ChemMedChem; 2014 Aug; 9(8):1660-4. PubMed ID: 24920093
[TBL] [Abstract][Full Text] [Related]
25. Ruthenium complexes as anticancer agents.
Kostova I
Curr Med Chem; 2006; 13(9):1085-107. PubMed ID: 16611086
[TBL] [Abstract][Full Text] [Related]
26. Synergistic cytotoxicity caused by forming a complex of copper and 2,9-dimethyl-1,10-phenanthroline in cultured vascular endothelial cells.
Nakamura T; Yoshida E; Fujie T; Ogata F; Yamamoto C; Kawasaki N; Kaji T
J Toxicol Sci; 2017; 42(6):683-687. PubMed ID: 29142167
[TBL] [Abstract][Full Text] [Related]
27. Cyclometalated Complexes of Platinum and Gold with Biological Properties: State-of-the-Art and Future Perspectives.
Jurgens S; Kuhn FE; Casini A
Curr Med Chem; 2018 Feb; 25(4):437-461. PubMed ID: 28554319
[TBL] [Abstract][Full Text] [Related]
28. Recent Trends in the Development of Novel Metal-Based Antineoplastic Drugs.
Todorov L; Kostova I
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838947
[TBL] [Abstract][Full Text] [Related]
29. Interactions of metal ions with DNA, its constituents and derivatives, which may be relevant for anticancer research.
Turel I; Kljun J
Curr Top Med Chem; 2011; 11(21):2661-87. PubMed ID: 22039873
[TBL] [Abstract][Full Text] [Related]
30. Novel metals and metal complexes as platforms for cancer therapy.
Frezza M; Hindo S; Chen D; Davenport A; Schmitt S; Tomco D; Dou QP
Curr Pharm Des; 2010 Jun; 16(16):1813-25. PubMed ID: 20337575
[TBL] [Abstract][Full Text] [Related]
31. Anticancer Activity and In Vitro to In Vivo Mechanistic Recapitulation of Novel Ruthenium-Based Metallodrugs in the Zebrafish Model.
Karas BF; Hotz JM; Gural BM; Terez KR; DiBona VL; Côrte-Real L; Valente A; Buckley BT; Cooper KR
Toxicol Sci; 2021 Jul; 182(1):29-43. PubMed ID: 33822233
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, characterization and biological evaluation of novel Ru(II)-arene complexes containing intercalating ligands.
Nikolić S; Rangasamy L; Gligorijević N; Aranđelović S; Radulović S; Gasser G; Grgurić-Šipka S
J Inorg Biochem; 2016 Jul; 160():156-65. PubMed ID: 26818702
[TBL] [Abstract][Full Text] [Related]
33. Copper complexes as anticancer agents.
Marzano C; Pellei M; Tisato F; Santini C
Anticancer Agents Med Chem; 2009 Feb; 9(2):185-211. PubMed ID: 19199864
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
[TBL] [Abstract][Full Text] [Related]
35. Coordination Complexes of Titanium(IV) for Anticancer Therapy.
Tshuva EY; Miller M
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394027
[TBL] [Abstract][Full Text] [Related]
36. The roles of copper transporters in cisplatin resistance.
Kuo MT; Chen HH; Song IS; Savaraj N; Ishikawa T
Cancer Metastasis Rev; 2007 Mar; 26(1):71-83. PubMed ID: 17318448
[TBL] [Abstract][Full Text] [Related]
37. Intracellular Catalysis with Selected Metal Complexes and Metallic Nanoparticles: Advances toward the Development of Catalytic Metallodrugs.
Soldevila-Barreda JJ; Metzler-Nolte N
Chem Rev; 2019 Jan; 119(2):829-869. PubMed ID: 30618246
[TBL] [Abstract][Full Text] [Related]
38. Metal complexes of curcumin for cellular imaging, targeting, and photoinduced anticancer activity.
Banerjee S; Chakravarty AR
Acc Chem Res; 2015 Jul; 48(7):2075-83. PubMed ID: 26158541
[TBL] [Abstract][Full Text] [Related]
39. NMR spectroscopy to study the fate of metallodrugs in cells.
Arnesano F
Curr Opin Chem Biol; 2021 Apr; 61():214-226. PubMed ID: 33882391
[TBL] [Abstract][Full Text] [Related]
40. Transferrin serves as a mediator to deliver organometallic ruthenium(II) anticancer complexes into cells.
Guo W; Zheng W; Luo Q; Li X; Zhao Y; Xiong S; Wang F
Inorg Chem; 2013 May; 52(9):5328-38. PubMed ID: 23586415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
